TetraLogic Pharmaceuticals Corporation
TLOG · OTC
12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Market Cap | $41 | $107 | $22 | $7 |
| - Cash | $15 | $13 | $55 | $5 |
| + Debt | $28 | $29 | $0 | $5 |
| Enterprise Value | $54 | $123 | -$33 | $7 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$43 | -$32 | -$17 | -$16 |
| % Margin | – | – | – | – |
| Net Income | -$56 | -$39 | -$23 | -$16 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.36 | -1.76 | -9.9 | -16.78 |
| % Growth | -34.1% | 82.2% | 41% | – |
| Operating Cash Flow | -$35 | -$32 | -$13 | -$16 |
| Capital Expenditures | -$0 | -$1 | -$0 | -$0 |
| Free Cash Flow | -$35 | -$33 | -$13 | -$16 |